Sudeep Pharma’s IPO opens quickly with robust financials and a stable market place, but additionally key dangers. Here’s a clear breakdown of its strengths, valuation and issues.
Sudeep Pharma IPO: The nice and the dangerous

Leave a comment

Sudeep Pharma’s IPO opens quickly with robust financials and a stable market place, but additionally key dangers. Here’s a clear breakdown of its strengths, valuation and issues.
Sign in to your account